πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 423 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9775911

Composition comprising a polymeric reagent

Nektar Therapeutics Β· Granted Tue Oct 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9763995

Polymer conjugates of protegrin peptides

Nektar Therapeutics Β· Granted Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9732189

Methods for preparing polymeric reagents and compositions of polymeric reagents

Nektar Therapeutics Β· Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9725431

Oligomer-tricyclic conjugates

Nektar Therapeutics Β· Granted Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9700529

Particulate materials

Nektar Therapeutics Β· Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9688638

Opioid agonists and uses thereof

Nektar Therapeutics Β· Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9682153

Polymer conjugates of therapeutic peptides

Nektar Therapeutics Β· Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9682988

Solid salt form of Ξ±-6-mPEG6-O-hydroxycodone as opioid agonists and uses thereof

Nektar Therapeutics Β· Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9670235

Oligomer-foscarnet conjugates

Nektar Therapeutics Β· Granted Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9636412

Conjugates of an anti-TNF-alpha antibody

Nektar Therapeutics Β· Granted Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9616136

N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides

Nektar Therapeutics Β· Granted Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9617228

Oligomer-containing substituted aromatic triazine compounds

Nektar Therapeutics Β· Granted Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9616060

Particulate materials

Nektar Therapeutics Β· Granted Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9579392

Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method

Nektar Therapeutics Β· Granted Tue Feb 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9539337

Compositions comprising two different populations of polymer-active agent conjugates

Nektar Therapeutics Β· Granted Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9540330

Oligomer-containing hydantoin compounds

Nektar Therapeutics Β· Granted Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9512135

Oligomer-opioid agonist conjugates

Nektar Therapeutics Β· Granted Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9504755

Multi-arm polymeric alkanoate conjugates

Nektar Therapeutics Β· Granted Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9493544

Von willebrand factor- and factor VIII-polymer conjugates having a releasable linkage

Nektar Therapeutics Β· Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9493609

N-maleimidyl polymer derivatives

Nektar Therapeutics Β· Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9487473

Oligomer-amino acid conjugates

Nektar Therapeutics Β· Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9458166

Oligomer-opioid agonist conjugates

Nektar Therapeutics Β· Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9446139

Polymer-based compositions and conjugates of HIV entry inhibitors

Nektar Therapeutics Β· Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9433684

Conjugates of small-interfering nucleic acids

Nektar Therapeutics Β· Granted Tue Sep 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted